You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
諾誠健華-B(09969.HK)年度虧損減少至4.64億元 研發成本達4.03億元
格隆匯 03-26 19:21

格隆匯3月26日丨諾誠健華-B(09969.HK)發佈公吿,截至2020年12月31日止年度,公司收益由上年度的人民幣120萬元增加至人民幣140萬元,主要由於南京諾誠健華向第三方提供的服務訂單增加所致。年內虧損由上年度的人民幣21.5億元減少至該年度的人民幣4.64億元。

虧損減少主要由於該年度可轉換可贖回優先股(已於首次公開發售後轉換為普通股)的公允價值變動錄得虧損人民幣1.42億元(上年度虧損為人民幣18.14億元),以及該年度主要因公司估值上升而導致可轉換貸款的公允價值變動的虧損減少至人民幣3240萬元(上年度虧損為人民幣1.6億元)。

研發成本由上年度的人民幣2.13億元增加至該年度的人民幣4.03億元,該增加主要是由於公司擴展臨牀試驗及股份支付增加所致。研發成本增加主要歸因於:(i)研發僱員成本由人民幣5020萬元增加人民幣3350萬元至人民幣8370萬元;(ii)第三方合約成本由人民幣3830萬元增加人民幣1700萬元至人民幣5530萬元;(iii)直接臨牀試驗開支由人民幣3750萬元增加人民幣1320萬元至人民幣5070萬元;及(iv)以股份支付薪酬由人民幣5720萬元增加人民幣1.14億元至人民幣1.72億元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account